Nash Beauty Clinic ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 6.4% 12.4% 13.9% 14.0%  
Credit score (0-100)  0 37 18 15 15  
Credit rating  N/A BBB BB BB BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  0.0 283 19.3 -22.2 13.5  
EBITDA  0.0 187 -20.1 -30.9 -14.7  
EBIT  0.0 177 -41.8 -52.6 -36.4  
Pre-tax profit (PTP)  0.0 173.3 -42.8 -59.3 -38.8  
Net earnings  0.0 134.4 -42.2 -59.1 -30.6  
Pre-tax profit without non-rec. items  0.0 173 -42.8 -59.3 -38.8  

 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 98.0 76.3 54.6 32.9  
Shareholders equity total  0.0 174 76.9 17.8 -12.8  
Interest-bearing liabilities  0.0 187 61.5 89.6 103  
Balance sheet total (assets)  0.0 602 187 149 119  

Net Debt  0.0 -300 -36.2 32.6 39.0  
 
See the entire balance sheet

Volume 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 283 19.3 -22.2 13.5  
Gross profit growth  0.0% 0.0% -93.2% 0.0% 0.0%  
Employees  0 1 1 0 0  
Employee growth %  0.0% 0.0% 0.0% -100.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 602 187 149 119  
Balance sheet change%  0.0% 0.0% -68.9% -20.5% -20.1%  
Added value  0.0 187.4 -20.1 -30.9 -14.7  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 87 -43 -43 -43  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 1.0 -1.0 -2.0 -3.0  

Profitability 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 62.6% -216.7% 236.5% -269.7%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 29.4% -10.6% -31.3% -25.9%  
ROI %  0.0% 48.9% -16.7% -42.7% -34.5%  
ROE %  0.0% 77.1% -33.6% -124.8% -44.8%  

Solidity 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  0.0% 29.0% 41.1% 12.0% -9.7%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% -160.2% 179.9% -105.5% -266.0%  
Gearing %  0.0% 107.0% 80.0% 503.2% -804.1%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 3.8% 0.8% 9.0% 2.7%  

Liquidity 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.0 1.2 1.0 0.7 0.6  
Current Ratio  0.0 1.2 1.0 0.7 0.7  
Cash and cash equivalent  0.0 486.8 97.7 57.0 63.8  

Capital use efficiency 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 77.2 0.8 -36.8 -45.7  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 187 -20 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 187 -20 0 0  
EBIT / employee  0 177 -42 0 0  
Net earnings / employee  0 134 -42 0 0